메뉴 건너뛰기
Journal of Oncology Practice
Volumn 11, Issue 1, 2015, Pages e28-e35
Reasons for delay in time to initiation of adjuvant chemotherapy for colon cancer
Author keywords

[No Author keywords available]
Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CENTRAL VENOUS CATHETER; COLON CANCER; COMORBIDITY; CONSULTATION; FEMALE; HUMAN; ILEUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; ONCOLOGIST; OVERALL SURVIVAL; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; THERAPY DELAY; TOTAL QUALITY MANAGEMENT; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLON TUMOR; HEALTH CARE DELIVERY; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; MULTICENTER STUDY; ONTARIO; STATISTICAL MODEL; TIME FACTOR;
EID: 84921382537     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2014.001531     Document Type: Article
Times cited : (27)
References (13)
  • 1
    • 0025060806 scopus 로고
    • Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma
    • Moertel CG, Fleming TR, Macdonald JS, et al: Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358, 1990
    • (1990) N Engl J Med , vol.322 , pp. 352-358
    • Moertel, C.G.1    Fleming, T.R.2    Macdonald, J.S.3
  • 2
    • 0031022988 scopus 로고    scopus 로고
    • Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
    • O'Connell MJ, Mailliard JA, Kahn MJ, et al: Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15:246-250, 1997
    • (1997) J Clin Oncol , vol.15 , pp. 246-250
    • O'Connell, M.J.1    Mailliard, J.A.2    Kahn, M.J.3
  • 3
    • 67650315187 scopus 로고    scopus 로고
    • Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial
    • André T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 3109-3116
    • André, T.1    Boni, C.2    Navarro, M.3
  • 4
    • 80053619762 scopus 로고    scopus 로고
    • Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses
    • Yothers G, O'Connell MJ, Allegra CJ, et al: Oxaliplatin as adjuvant therapy for colon cancer: Updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 29:3768-3774, 2011
    • (2011) J Clin Oncol , vol.29 , pp. 3768-3774
    • Yothers, G.1    O'Connell, M.J.2    Allegra, C.J.3
  • 5
    • 33751581368 scopus 로고    scopus 로고
    • Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
    • Hershman D, Hall MJ, Wang X, et al: Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer 107:2581-2588, 2006
    • (2006) Cancer , vol.107 , pp. 2581-2588
    • Hershman, D.1    Hall, M.J.2    Wang, X.3
  • 6
    • 79958035214 scopus 로고    scopus 로고
    • Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis
    • Biagi JJ, Raphael MJ, Mackillop WJ, et al: Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis. JAMA 305:2335-2342, 2011
    • (2011) JAMA , vol.305 , pp. 2335-2342
    • Biagi, J.J.1    Raphael, M.J.2    Mackillop, W.J.3
  • 7
    • 77949488886 scopus 로고    scopus 로고
    • Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis
    • Des Guetz G, Nicolas P, Perret GY, et al: Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer 46:1049-1055, 2010
    • (2010) Eur J Cancer , vol.46 , pp. 1049-1055
    • Des Guetz, G.1    Nicolas, P.2    Perret, G.Y.3
  • 11
    • 68049125885 scopus 로고    scopus 로고
    • Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for stage II and III rectal cancer
    • Cheung WY, Neville BA, Earle CC: Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for stage II and III rectal cancer. Dis Colon Rectum 52:1054-1063, 2009
    • (2009) Dis Colon Rectum , vol.52 , pp. 1054-1063
    • Cheung, W.Y.1    Neville, B.A.2    Earle, C.C.3
  • 12
    • 79958024180 scopus 로고    scopus 로고
    • Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada
    • epub ahead of print on February 11
    • Lima IS, Yasui Y, Scarfe A, et al: Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer [epub ahead of print on February 11, 2011]
    • (2011) Cancer
    • Lima, I.S.1    Yasui, Y.2    Scarfe, A.3
  • 13
    • 80053091155 scopus 로고    scopus 로고
    • Time to initiation of adjuvant chemotherapy and survival in colorectal cancer
    • Sargent D, Grothey A, Gray R: Time to initiation of adjuvant chemotherapy and survival in colorectal cancer. JAMA 306:1199, 2011
    • (2011) JAMA , vol.306 , pp. 1199
    • Sargent, D.1    Grothey, A.2    Gray, R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.